FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387122008: Glycopyrronium bromide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1481232014 Glycopyrrolate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2672945019 Glycopyrronium bromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3482237018 Glycopyrronium bromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
815061000172117 glycopyrronium bromure fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glycopyrronium bromide Is a Muscarinic receptor antagonist true Inferred relationship Some
Glycopyrronium bromide Is a Antispasmodic (substance) true Inferred relationship Some
Glycopyrronium bromide This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Muscarinic receptor antagonist (disposition) true Inferred relationship Some
Glycopyrronium bromide This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Glycopyrronium (substance) true Inferred relationship Some
Glycopyrronium bromide Is a Quaternary ammonium compound with anticholinergic mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
bromure de glycopyrronium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium adverse reaction Causative agent (attribute) False Glycopyrronium bromide Inferred relationship Some
Allergy to glycopyrronium Causative agent (attribute) False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide [antispasmodic] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide [anesthesia] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 200micrograms/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 600micrograms/3mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 0.2mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Product containing glycopyrronium bromide in oral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Product containing glycopyrronium bromide in parenteral dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 100%w/w powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Neostigmine 2.5mg/glycopyrronium 500mcg injection solution 1mL ampule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Neostigmine+glycopyrronium The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 0.2mg/mL injection solution 1mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 0.2mg/mL injection solution 5mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 0.2mg/mL injection solution 20mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 0.2mg/mL injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 100%w/w powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide Is a False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide [anesthesia] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide [antispasmodic] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 600micrograms/3mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrrolate 200micrograms/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Allergy to glycopyrronium Causative agent (attribute) False Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 2 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 2 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 1 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glycopyrronium bromide Inferred relationship Some 1
Product containing glycopyrronium bromide and neostigmine bromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Product containing formoterol and glycopyrronium bromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Product containing glycopyrronium bromide and indacaterol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Product containing formoterol and glycopyrronium bromide in respiratory dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Product containing glycopyrronium bromide and indacaterol in respiratory dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Glycopyrronium bromide Inferred relationship Some
Glycopyrronium bromide 1 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 2 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium bromide 200 microgram/1 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium bromide 600 microgram/3 milliliter conventional release solution for injection ampule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium bromide 600 microgram/3 milliliter conventional release solution for injection ampule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Glycopyrronium bromide Inferred relationship Some 2
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Glycopyrronium bromide Inferred relationship Some 2
Glycopyrronium bromide 200 microgram/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 200 microgram/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Glycopyrronium bromide Inferred relationship Some 1
Glycopyrronium (as glycopyrronium bromide) 320 microgram/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium (as glycopyrronium bromide) 160 microgram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glycopyrronium bromide Inferred relationship Some 1
Product containing precisely glycopyrronium (as glycopyrronium bromide) 44 microgram/1 actuation conventional release powder for inhalation (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Glycopyrronium bromide Inferred relationship Some 1

This concept is not in any reference sets

Back to Start